Print
Email

Email

Sector Update: Health Care

Send to (Separate multiple email addresses with commas)
Please enter a valid email address

Your email address
Please enter a valid email address

Message (Optional)

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Email

Your email has been sent.
Share
Share
Sector Update: Health Care

Clicking a link will open a new window.
Default text size A
Larger text size A
Largest text size A

Sector Update: Health Care

, MT Newswires - 8:54 AM ET 4/4/2025 US Markets

08:54 AM EDT, 04/04/2025 (MT Newswires) -- Health care stocks declined pre-bell Friday with the Health Care Select Sector SPDR Fund (XLV) down 0.5% and the iShares Biotechnology ETF (IBB) 1.6% lower recently.

Mesoblast (MESO) said it considers its allogeneic cellular therapies, including Ryoncil and Revascor, to be US-origin products that will not be subject to tariffs. Shares of Mesoblast fell by nearly 7% premarket.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

Sector Update: Health Care

Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.

Your e-mail has been sent.

Japan's Nikkei climbs on upbeat US trade talks, TSMC earnings beat

Reuters - 2:55 AM ET 4/17/2025
Netflix, UnitedHealth Group And 3 Stocks To Watch Heading Into Thursday

Benzinga - 2:52 AM ET 4/17/2025
Japan's bond yields rise after upbeat trade talks in Washington

Reuters - 1:44 AM ET 4/17/2025
Japan's Nikkei rebounds, yen weakens as trade talks begin in Washington

Reuters - 11:47 PM ET 4/16/2025
Top 5 Trending Stocks: Palantir, Hertz, Netflix, Prologis, Tesla

Benzinga - 11:29 PM ET 4/16/2025
Scott Bessent Warns Of 'Serious Risk' To Anyone Buying Iran Oil â Crude Moves Up, US Futures And Nikkei Post Modest Gains

Benzinga - 10:41 PM ET 4/16/2025
Tariff-wounded stocks find no balm with Powell remarks

Reuters - 6:38 PM ET 4/16/2025

Content for this page, unless otherwise indicated with a Fidelity pyramid logo, is selected and published by Fidelity Interactive Content Services LLC ("FICS"), a Fidelity company. All Web pages published by FICS will contain this legend. FICS was established to present users with objective news, information, data and guidance on personal finance topics drawn from a diverse collection of sources including affiliated and non-affiliated financial services publications. Content selected and published by FICS drawn from affiliated Fidelity companies is labeled as such. FICS-selected content provided is not intended to provide tax, legal, insurance, or investment advice, and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by any Fidelity entity or any third party. Quotes are delayed unless otherwise noted. FICS is owned by FMR LLC and is an affiliate of Fidelity Brokerage Services LLC. Terms of use for Third-Party Content and Research

These links are provided by Fidelity Brokerage Services LLC ("FBS") for educational and informational purposes only. FBS is responsible for the information contained in the links. FICS and FBS are separate but affiliated companies and FICS is not involved in the preparation or selection of these links, nor does it explicitly or implicitly endorse or approve information contained in the links.

Before investing, consider the funds' investment objectives, risks, charges, and expenses. Contact Fidelity for a prospectus or, if available, a summary prospectus containing this information. Read it carefully.